Concomitant use of oxycodone HCl with CYP3A4 inducers or discontinuation of the CYP3A4 inhibitor could reduce oxycodone plasma concentrations, minimize opioid efficacy or, quite possibly, produce a withdrawal syndrome in a very patient who experienced designed Actual physical dependence to oxycodone